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Cardiovascular disorders account for nearly 1 in 3 deaths in the United States. Care for these disorders are often determined during visits
to acute care facilities, such as hospitals. While the length of stay in these settings represents just a small proportion of patients’ lives,
they account for a disproportionately large amount of decision making. To overcome this bias towards data from acute care settings,
there is a need for longitudinal monitoring in patients with cardiovascular disorders. Longitudinal monitoring can provide a more
comprehensive picture of patient health, allowing for more informed decision making. This work surveys the current field of sensing
technologies and machine learning analytics that exist in the field of remote monitoring for cardiovascular disorders. We highlight
three primary needs in the design of new smart health technologies: 1) the need for sensing technology that can track longitudinal
trends in signs and symptoms of the cardiovascular disorder despite potentially infrequent, noisy, or missing data measurements; 2)
the need for new analytic techniques that model data captured in a longitudinal, continual fashion to aid in the development of new
risk prediction techniques and in tracking disease progression; and 3) the need for machine learning techniques that are personalized
and interpretable, allowing for advancements in shared clinical decision making. We highlight these needs based upon the current
state-of-the-art in smart health technologies and analytics and discuss the ample opportunities that exist in addressing all three needs
in the development of smart health technologies and analytics applied to the field of cardiovascular disorders and care.
CCS Concepts: •Applied computing→Health informatics; Health care information systems; •Computer systems organization
→ Embedded systems; • Information systems→ Data analytics; • Computing methodologies→ Machine learning.
Additional Key Words and Phrases: cardiovascular disease, patient analytics, longitudinal monitoring, smart health, sensors
ACM Reference Format:
Nathan C. Hurley, Erica S. Spatz, Harlan M. Krumholz, Roozbeh Jafari, and Bobak J. Mortazavi. 2019. A Survey of Challenges and
Opportunities in Sensing and Analytics for Cardiovascular Disorders. ACM Trans. Comput. Healthcare XX, Y, Article Z (August 2019),
32 pages. https://doi.org/10.1145/nnnnnnn.nnnnnnn
1 INTRODUCTION
Cardiovascular diseases are the worldwide leading cause of death [12]. In 2016, cardiovascular diseases accounted for
nearly 1 in 3 deaths in the United States. Real-time vital monitoring allows for care providers to track patient progress
and to rapidly respond to any changes in patient condition. In the hospital, monitoring patients is part of routine
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clinical practice. Providers are able to monitor cardiac status and basic vitals from anywhere in the hospital at any time.
Slight deteriorations in health can be observed and interventions put into place before patients suffer worsening harm.
However, length of stay in these acute care settings is often quite short [10, 107], representing only a small portion
of a patient’s life. Monitoring physiologic parameters and symptoms outside of the hospital setting can enable better
detection and response systems before a person becomes acutely ill and requires hospitalization or after hospitalization
to prevent early readmission to the hospital; however, many of the devices today are targeted to healthy people. With
the prevalence and ubiquitous nature of remote and wearable sensors, opportunities exist to broaden the applications
of sensing and for adapting analytic techniques to enhance diagnosis, monitoring, and treatment among people with
cardiovascular disease.
A challenge in monitoring patients with cardiovascular disorders is designing the technology and algorithms to
support a variety of conditions and signs/symptoms, including heart failure (HF), coronary artery disease (CAD), and
stroke, along with risk factors for these conditions such as hypertension (HTN). HF is typically a chronic condition
where the heart is unable to drive blood forward through the body sufficiently or can only do so under damagingly high
pressures. HF is a debilitating disease that causes significant global disease burden. In 2016, HF was the most rapidly
growing cardiovascular condition in the world [115]. CAD occurs when blood flow through the coronary arteries,
the small arteries that provide blood to the heart, becomes impeded. This occurs both gradually as plaque builds up
within the coronary arteries and suddenly when a plaque ruptures and clots. The former causes chest pain and exercise
intolerance, while the latter, commonly known as a heart attack, can cause severe pain, loss of consciousness, and death.
Each year around 800,000 Americans suffer a heart attack, and rapid care following a heart attack is a chief predictor
for minimizing long term morbidity and mortality [49, 62, 70]. Stroke is any disease impacting the blood vessels to the
brain. In particular, acute stroke is a condition that occurs when either a blood vessel in the brain ruptures, or when one
of those blood vessels becomes blocked. Stroke manifests with the sudden onset of neurological deficits, some of which
may be irreversible. Stroke is the fifth leading cause of death in the United States and is a leading cause of long-term
disability [12]. HTN is a disease in which the arterial blood pressure (BP) is chronically elevated. This elevation may
remain asymptomatic for years but can ultimately lead to damage of multiple organ systems. HTN is a very common
condition, with middle-aged Americans having approximately 90% lifetime risk of developing HTN [102].
Patients with cardiovascular disorders present a number of challenges for remote monitoring and diagnosis because
of complexities within the diseases. Many of these diseases involve seemingly trivial symptoms that may suddenly
change from a minor inconvenience to a debilitating lack of function. A patient with a given disease may feel well for
multiple years, and then suddenly decompensate and require emergent care. Ideally, remote monitoring should be able to
track the slow, daily progression of a disease and alert the patient and healthcare providers to worsening disease before
decompensation and patient suffering. However, preliminary studies in remote monitoring have failed at preventing
adverse events, such as in preventing repeated hospital admissions in patients diagnosed with HF. For example, the
Telemonitoring in Patients with Heart Failure trial (Tele-HF) used patient self-reports of daily changes in symptoms,
weight, and a variety of other factors (e.g., medication changes, depression scores, etc.) to identify worsening symptoms
in an effort to intervene prior to another acute event, but did not find a statistically significant difference between
control and intervention arms [17]. However, an analysis of participant subgroups did find that patient self-reported
data could improve prediction of readmission likelihood, showing potential for more advanced analytic techniques
to better identify participant risk and to improve estimates in this space [48]. A further exploration in automating
the capture of relevant biometric signals, including heart rate, blood pressure, and weight, was similarly unable to
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find a statistically significant difference in control and intervention arms [75], suggesting that further exploration of
additional biomedical signals are needed.
Remote sensing technologies have increased in prevalence and have made personalized health data collection feasible.
In human activity recognition (HAR), wearable sensors and inertial measurement units embedded within smartphones
and smartwatches have enabled the tracking of detailed motions [8, 51]. Coupled with nearable sensors that capture
motion via video, these sensing systems allow for the tracking of motions of healthy participants [18] to tracking of
disease state with custom-built sensors, such as smartshoes [25]. The data provided by these wearable and remote
sensors has more recently enabled advanced machine learning techniques to identify more complex patterns of motions,
better understanding personalized behavior [39, 104]. Eventually, these techniques have emerged to personalize models
of activity recognition to individual users, providing the most robust interpretation of activities of daily living per user
[89], enabling feedback and the measurement of clinical outcomes [23]. This progression from the development of
new sensing modalities to the analytic techniques that detect patterns within the data and finally to personalization in
tracking and disease progression modeling is a pathway that should be leveraged for more advanced clinical disorders.
The development of new sensors to measure signs and symptoms of cardiovascular disorders would ideally enable a
similar progression for tracking of cardiovascular outcomes. These new sensors would be able to identify conditions
that may not be apparent to patients or providers, such as different sounds from the heart, slowly decreasing patterns of
activity, or combination of vitals that may appear normal in isolation but may be indicative of risk given a combination
of values and certain patient contexts. By identifying dangerous signs before symptoms manifest, earlier interventions
can lead to improved health outcomes. A variety of technologies and machine learning techniques to this purpose exist
in condition-specific settings [28, 67] to varied success [29, 36, 68]. Understanding the pathologies of the disorders is
important in understanding the clinical needs and opportunities that exist in developing new wearable and remote
sensors for diagnosis and treatment of a variety of cardiovascular conditions and using advanced analytic techniques
that are enabled from the collection of new, comprehensive patient data.
In this survey, we discuss different sensing modalities that have been or that could be applied to tracking cardiac
health in remote settings; in addition, we consider the opportunities that advanced analytic strategies present with
the acquisition of remote sensing data for continuous risk modeling. As cardiac pathologies manifest, they can also be
indirectly observed through physical changes in the body, potentially measured by sensors on or around the body. These
changes can be utilized to track patient health, to plan interventions to maximize patient wellness, and to decrease the
overall impacts of the disease. One of the oldest technologies used for assessing cardiac health is the stethoscope. In
the digital era, the electronic stethoscope is a varied group of technologies that incorporate a microphone in order to
automate acoustic diagnose and facilitate remote monitoring [52]. Other technologies, such as photoplethysmography
and sphygmomanometry, allow for remote measurement of the characteristics of the blood flow including heart rate
and blood pressure [114]. Doppler radar can detect vital signs such as respiratory rate and heart rate [54]. Electrical
techniques such as electrocardiography (ECG) or other conduction studies such as Bioimpedance can give insights into
the internal physiology of the heart [105].
Sensing systems provide for opportunities to proactively detect and alert patients and physicians to worsening
health states. However, to allow for timely and effective interventions as well as to rapidly evaluate the impact of
those interventions, development of advanced signal processing and machine learning techniques need to keep pace
with the development of raw sensor modalities. This paper presents a survey of state-of-the-art sensing technologies
and analytics with respect to monitoring cardiovascular disorders, in order to highlight successes and provide areas
for additional growth. Two key ways in which analytics associated with sensing systems can provide support are to
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monitor for the start of new disease and to track the progression of preexisting disease. Tracking the progression of
existing disease is the easier task: once an underlying disease state is known, appropriate monitoring can be put into
place and utilized to follow the progression of the disease. Monitoring for the start of new disease is more difficult, as
the focus is more general. In either case, sensing and clinical characteristics can be combined for decision support with
the aid of machine learning approaches. In this paper, we survey the current state of the art in patient monitoring and
analytics for patient risk and care, highlighting needs and opportunities for advancements in the field of smart health
with respect to monitoring signs, symptoms, and treatments in patients diagnosed with cardiovascular disorders. The
workflow described in this paper towards developing new tools for remote clinical decision support is shown in Figure
1.
2 CASE STUDIES AND NEEDS
This work considers three primary cardiovascular disorders for the review of gaps and opportunities, though by no
means encompasses the entirety of technologies available for monitoring and treating these conditions nor the entirety
of conditions to which these technologies could be applied. Instead, these conditions serve as meaningful examples in
which technical solutions would be clinically impactful, following the same trajectory of development discussed in the
prior section with regards to HAR. Those conditions are heart failure (HF), coronary artery disease (CAD), and stroke,
with an additional emphasis on hypertension (HTN) as an important and common risk factor for these conditions. We
briefly review these conditions and use them as case studies to discuss the current needs in smart health technologies.
2.1 Clinical Conditions
Heart failure (HF) occurs when one or both halves of the heart are unable to drive blood flow forward at the rate
required by the body or can only do so under high pressures. This discussion of pathology will focus primarily on
left-sided HF rather than right-sided HF, but the two are often closely associated and technologies for monitoring
the two will have a large amount of overlap. The two will also often coexist. HF can result from ineffective heart
contractions, from high pressure limiting the effect of heart contractions, or from difficulty in filling the heart. The first
two causes lead to HF with reduced ejection fraction (HFrEF), and the last leads to HF with preserved ejection fraction
(HFpEF). Ineffective heart contractions can result from muscle damage caused by CAD, by chronic volume overload as
seen in mitral regurgitation (MR) or aortic regurgitation (AR), or by a family of cardiac muscle disorders known as
cardiomyopathies. High pressure can lead to HF either from aortic stenosis (AS) or from uncontrolled hypertension. In
either case, the pressure that the heart has to work against is so high that the pumping becomes ineffective. Difficulty
in filling the heart can be caused by ventricular hypertrophy, cardiomyopathy, fibrosis, disease around the outside of
the heart (the pericardium), or by CAD.
Coronary artery disease (CAD) is a family of diseases where blood flow through the small arteries of the heart,
the coronary arteries, is restricted. This restriction can be caused by deposits of fatty plaques within the arteries, or
by clotting caused by the rupture of one of these plaques. Depending on the extent of the blood flow restriction and
the current oxygen demands of the heart, CAD may cause different symptoms. CAD is represented by a spectrum of
conditions that are defined by specific clinical and physiological signs.
Stroke occurs when blood supply in and around the brain is acutely disrupted, and results in acute neurologic defects.
Ischemic stroke is a type of stroke where a blockage in cerebral arteries rapidly blocks off blood flow, leading to cell
death. Hemorrhagic stroke is a type of stroke where a blood vessel in the brain ruptures, rapidly raising pressure inside
the skull and causing cell death. Transient ischemic attacks (TIAs) are similar in cause and presentation to strokes
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Fig. 1. Overview of a workflow to developing personalized, remote clinical decision support tools for patients with cardiac disorders.
Needs are shown in three categories: needs in sensor development and data handling, needs in continuous data collection and
analysis, and needs in developing comprehensive and personalized analytical models. Addressing these three categories will allow for
improved personalized remote clinical decision support for patients with cardiac disorders.
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but resolve spontaneously. They are often an indicator of underlying disease and put the patient at increased risk for
future TIA or stroke. The neurological pathology goes beyond the scope of this work, but there are several notable
cardiovascular impairments that may cause a stroke.
Hypertension is a condition where a patient’s blood pressure is persistently elevated and is often a condition that
serves as a modifiable precursor to each of the three cardiovascular disorders discussed [74]. Hypertension is divided by
cause into two categories: primary (or essential) hypertension is hypertension without a particular medical cause, while
secondary hypertension is hypertension caused by some other medical condition. Primary hypertension accounts for
roughly 90% of all hypertension, while secondary hypertension accounts for the remaining 10%. Causes of secondary
hypertension include renal disease and endocrine diseases that disrupt the body’s natural control of blood pressure [76].
Essential hypertension is a diagnosis of exclusion, and requires ruling out the possibility of any secondary causes. Risk
factors for essential hypertension include both hereditary and environmental factors [85]. There is a strong association
between hypertension, obesity, and insulin resistance. Hypertension is associated with poor diet, excessive alcohol
intake, and age. Additional discussion of normal cardiac physiology can be found in the Supplementary Appendix
(Section A).
2.2 Needs for Monitoring Cardiovascular Disorders
Figure 2 illustrates the three primary needs this survey will discuss: 1) the need for sensing technology that can
track longitudinal trends in signs and symptoms of the cardiovascular disorder despite potentially infrequent, noisy,
or missing data measurements; 2) the need for new analytic techniques that model data captured in a longitudinal,
continual fashion to aid in the development of new risk prediction techniques and in tracking disease progression; and
3) the need for machine learning techniques that are personalized and interpretable, allowing for advancements in
shared clinical decision making. A number of varied signs and symptoms exist for HF, CAD, and stroke. The remainder
of this section briefly introduces some common signs and symptoms. Here, a symptom is a change caused by disease
that is noticed by and likely an irritant to the patient, while a sign is a change that the patient may not notice or that
may not be concerning to the patient.
In HF, the symptoms result both from insufficient blood flow and from excess fluid buildup. The three main symptoms
that are associated with diagnosis of HF and quantification of its severity are dyspnea (shortness of breath) on exertion;
sudden, choking dyspnea at night; and difficulty breathing while lying down. In left-sided HF pulmonary vein pressure
increases, causing buildup of fluid in the lungs (pulmonary edema) that worsens while lying down. In right-sided HF
systemic venous congestion results in fluid buildup in the periphery (peripheral edema) that worsens while upright,
resulting in noticeable swelling in the wrists and ankles. HF is difficult to precisely define as it is a clinical syndrome
resulting from many different heart conditions, and many variants exist. Therefore, attempts to understand HF and
to monitor its progression must focus on identifying the symptoms and identifying cardiac dysfunctions. Symptoms
that can be measured include peripheral edema (swelling of ankles, rapid weight gain), decreased activity, and changes
in respiratory patterns when lying down versus remaining upright. Changes in blood flow to the kidneys result in
decreased urine production during the day, and increased urine production at night. Patients with HF will therefore
often get up frequently in the night. These patients will also likely change posture in the night, with patients with
advanced HF needing to sleep upright. One of the most used classification schemes for HF is the New York Heart
Association (NYHA) Functional Classification [53]. In this classification scheme, classes are separated based on the
physical activity that the patient is able to achieve and the discomfort that results from physical activity. Class I is when
no symptoms are present, and in Class IV the patient is unable to perform any physical activity without discomfort and
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Fig. 2. Progress from sensors to analytics (y axis) and how they relate to each of the three conditions (x axis).
symptoms of heart failure are never alleviated. As can be seen, a variety of sensing modalities could be employed to
track signs and symptoms of HF, from measurements of peripheral blood flow, respiration rate, exercise capacity, and
posture while sleeping. This illustrates the need for new sensors that can measure each of these various symptoms.
However, not every sensor may be worn at all times, due to excessive burden on the user. Therefore, there is a need
for new sensing modalities that can track different patterns and trends in captured data, as well as transfer learning
techniques that can be adapted to estimate values of sensors that may be malfunctioning or not worn.
If the right set of sensors are selected and are designed to be worn longitudinally, new patterns and trends in signs
and symptoms might be detected. In CAD, for example, restrictions in blood flow of the coronary artery may result in a
condition called stable angina (SA). The rate at which the restrictions in blood flow occur, however, might change as the
disease progresses. At some point, the restriction responsible for SA may rapidly increase, producing a situation where
the patient is in emergent need of medical care. The most common way for this progression to occur is for a fatty plaque
to rupture, leading to the formation of a clot that blocks blood flow. The first disease after this point is unstable angina
(UA). As the restriction increases to a partial occlusion, the patient will experience chest pain that worsens without
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activity or that is not relieved with rest. Both stable and unstable angina present similarly in a patient. Typically, the
patient will have episodes of chest pain that last from 3-10 minutes, but potentially lasting up to 30 minutes. This pain
may radiate to the jaw, neck, shoulder, or arm. The patient will likely feel short of breath and may also experience
nausea. If the patient takes a medication called nitroglycerine, the pain should resolve within 1-3 minutes. In UA,
damage is still reversible, but intervention is emergently necessary to ensure that the disease does not progress. If UA
progresses, it will progress to a condition commonly known as a heart attack, or in medical terminology as a myocardial
infarction (MI). There are two types of MI: non-ST-elevation MI (NSTEMI), and ST-elevation MI (STEMI). In NSTEMI,
some muscle in the heart has begun to die, and therefore at least some of the damage caused is irreversible. In a STEMI,
there is a complete blockage of blood flow at some point and a large amount of muscle in the heart has begun to die.
NSTEMI and STEMI are distinguished by characteristic findings on ECG; in a STEMI, the ST segment will be elevated
above the baseline in some leads, while this elevation is absent in NSTEMI. The leads showing this change reflect the
area of the heart impacted by the MI. This demonstrates the second need, longitudinal monitoring of continuous signals
that can identify disease progression, and machine learning techniques that can account for the personal progression
and varied rates of this progression.
In order to prevent conditions such as stroke, interventions are necessary in known risk factor conditions, such as
hypertension. Hypertension can lead to stroke in multiple ways. Very high blood pressure raises the risk of hemorrhagic
stroke, as blood vessels in the brain may not be able to support higher pressures. Additionally, chronic hypertension is
the main risk factor associated with ischemic stroke. The diagnosis of hypertension requires repeated blood pressure
measurements (sustained hypertension), as measured by ambulatory blood pressure measurements. Various reasons for
blood pressure elevation must be identified, including white coat hypertension (when the blood pressure is elevated
during a visit to a doctor but normal when measured in home settings), masked hypertension (when blood pressure
is regularly elevated but detected as normal during a visit to a doctor), and evaluation in changes of blood pressure
when sleeping versus when awake (nocturnal nondipping hypertension). Hypertension typically does not manifest
with any symptoms, as the body is very good at masking the feeling of this pressure. Although high blood pressure has
been colloquially associated with stress, headaches, or dizziness, these symptoms are typically not caused by chronic
hypertension. The primary sign (and part of the diagnostic criteria) of hypertension is an elevated blood pressure. For
diagnosis, at least two measurements on two different occasions of blood pressure above 120/80 mmHg are required.
More recently, guidelines have suggested measuring blood pressure with an ambulatory blood pressure monitor over a
24-hour period, measuring blood pressure every 15 minutes during the day and every 30 minutes during sleep at night,
and using the average values to have a better understanding of a patient’s blood pressure [31]. This sustained elevation
may result in stiffer arteries, reducing arterial compliance. Additionally, over time, this chronic elevation may result
in left ventricular hypertrophy seen on ECG or in changes in the retina. Most patients with hypertension are largely
asymptomatic, with the chief clinical sign being that of elevated blood pressure. When symptoms of hypertension do
manifest, they are largely caused by organ damage that results from chronically elevated blood pressures. Chronically
elevated blood pressure can lead to heart damage, as the heart must work harder than normal to produce these elevated
pressures. This can lead to HF as the heart gains mass and loses efficiency, or to CAD as the increased mass of the
heart requires increased myocardial oxygen supply. Chronically elevated blood pressure can also lead to damage of
the arteries. This can lead to atherosclerosis, where plaque buildups can compromise coronary arteries, leading to
CAD or cerebral arteries, leading to stroke. Weakening of arterial walls can lead to kidney disease or to retinal disease.
Advanced hypertension can cause changes to the eye that can be observed visually by a physician. The definition of
high blood pressure has undergone changes in recent years, with the SPRINT trial indicating that aggressive treatment
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of blood pressure to <120/<80 mmHg is associated with decreased mortality [32]. The potential measurement of blood
pressure from new sensing modalities can enable analytic techniques to identify cases of hypertension and evaluate
the effectiveness of medication on reducing blood pressure, such as in the SPRINT trial. This illustrates the third need,
where machine learning techniques, trained on continual data captured from new sensing modalities (the prior two
needs), must provide actionable, interpretable estimations of signs, symptoms, and disease progress, in order to help
guide treatment decision making and evaluate treatment effectiveness both prior to a diagnosis of a cardiovascular
disorder and in the treatment and evaluation of recovery from an adverse cardiovascular event.
In the following sections, we explore the state of the art in technology associated with each of the needs. This
survey reviews the technology available, the gaps that remain in addressing the needs, and highlights opportunities for
researchers within the smart health field to design solutions with impact to clinical decision-making problems.
3 NEW SENSORS, TRENDS IN LONGITUDINAL CAPTURE, MISSING DATA, AND SENSOR SELECTION
The management of HF, CAD, and stroke can benefit from new sensing techniques by capturing acute data as well as
detecting changes in sensed data over time. Each has unique signs and symptoms that manifest through a variety of
changes in the body. For HF, improper blood flow can result in fluid retention (edema) in the lungs or the periphery, as
well as develop signs of heart remodeling. Heart remodeling can be evidenced by third and fourth heart sounds (S3 and
S4), as well as by a laterally or inferiorly displaced point of maximal impulse (PMI) of the heart on physical exam; the
place where the heartbeat can be felt most strongly will migrate down and to the left of the thorax. One way in which
improper blood flow can be detected is that the extremities will be cooler than normal.
In CAD, stable and unstable angina will often result in physical pain felt by the patient in an episode that may
last up to 30 minutes in the chest that may also radiate to the jaw neck and arm. The patient’s heart rate and blood
pressure will initially be elevated, although these can potentially decrease in NSTEMI and STEMI as the heart fails to
operate optimally. The patient will breathe more quickly and will put more effort into breathing. Additionally, abnormal
sounds may be heard with a stethoscope. It is possible for rales, an abnormal lung sound, to be heard at the posterior
base of each lung. During chest pain, an ECG will show ST-segment depression, but this will change and progress to
ST-segment elevation in STEMIs.
For stroke, this work focuses on the signs and symptoms that might lead to a stroke. Atrial fibrillation (AFib) is a
relatively common arrhythmia that increases risk of stroke. AFib results when the atria of the heart beat ineffectively
and randomly, causing turbulence within the atria. This turbulent flow allows for clots to form within the atria. If these
clots are dislodged, they may travel through the arteries and become lodged in the brain, causing an ischemic stroke.
AFib is classically defined as an “irregularly irregular” beat- the beat is not a typical rhythm (irregular) and additionally
has no pattern determining when beats occur (irregularly). This is most often seen as absent P waves on ECG with
variably occurring QRS complexes over a noisy baseline. However, this pattern could be detected by many techniques
that measure pulse. Chief risk factors that predispose patients to AFib are age, other heart disease, diabetes, and chronic
lung disease. HTN can also lead to stroke in multiple ways. Very high blood pressure raises the risk of hemorrhagic
stroke, as blood vessels in the brain may not be able to support higher pressures. Chronic hypertension is the main risk
factor associated with ischemic stroke.
These cardiac conditions present a range of sensing opportunities:
• Acoustic measurement: capture of heart sounds to identify specific classes as well as respiratory effort are
important in understanding acute conditions and changes in heart function over time. This also includes
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respiratory distress when lying down, causing patients diagnosed with HF to need to sleep in a more upright
position.
• Electrical Measurement: Remote ECG measurements can identify periods of atrial fibrillation and other arrhyth-
mias or help identify progression of CAD during an acute event.
• Blood flow: Understanding cardiac output, as well as measurement of blood pressure, is an important risk factor
that needs periodic measurement.
• Fluid Retention/Weight Change: HF often results in lung and peripheral edema that results in swelling and can
be measured by cooler temperatures in the periphery and changes in weight.
• Physical activity and pain: In all cases, patient self-reported pain, fatigue, and physical activity may be sur-
rogates for worsening conditions. Activity recognition can include posture detection to link with respiratory
measurements.
3.1 Existing Technologies and Applications
3.1.1 Acoustic Sensing/Vitals. Vital sign monitoring has been explored through a variety of technologies. Each sensor
type has been designed to address some of the sensing needs described in the previous section in an effort to replace
or replicate tools available in acute care settings for remote environments. The stethoscope is one of the oldest such
tools in medicine and is an implementation of acoustic sensing. By hearing and interpreting sounds from the patient,
the physician can develop insights into the health of the patient and the functionality of the organs. Recently, digital
stethoscopes have been utilized to better capture sounds. Digital stethoscopes provide benefit in allowing soft sounds to
be more easily heard, but also allow for recording of sounds for later manual or computational analysis. As physicians
have grown more reliant on advanced imaging techniques such as ultrasound, physical exam skill, including skill at
auscultation, has decreased [20].
Developing a digital stethoscope involves multiple components requiring heart sound capture, segmentation of
the audio signal, and understanding of the cardiac cycle, best paired with an external signal such as ECG or pulse to
determine the reference interval [52]. A limitation here is that the time from electrical activity to sound production is
not constant in all samples. Direct segmentation techniques involve utilizing Shannon energy to calculate an envelope
and to find its peaks, and then use those peaks to reconstruct the cardiac cycle. Techniques applied to analyzing this
data include machine learning techniques to classify the sounds, including support vector machines (SVM), artificial
neural networks (ANN), hidden markov models (HMM), and gaussian mixture models (GMM), for identifying sounds
and identifying next likely sound given the state in the heart beat cycle currently detected. These techniques have
accuracies near 90% for classifying signals as either normal or as having aortic or mitral valvular lesions.
Work has also been done to develop low-cost devices that can act as a bridge between a traditional stethoscope and a
cell phone [93]. Constructing a cavity with good resonance is necessary in collecting good quality sound transmissions
from the stethoscope. In particular, Sinharay et al. have evaluated using different kind of sensors to capture sounds to
be transmitted from and to smartphones for analysis.
In addition to detecting abnormal sounds in the cardiac cycle, there has been successful work in eliciting heart
pathology from abnormalities within normal heart sounds. In particular, the normal cycle is composed of two sounds-
one from the aortic valve closing and the other from the pulmonic valve closing. Both happen at nearly the same time,
typically creating a single sound. However, some heart pathologies can impact the time between these. In a study of
pediatric patients, high pressure in the pulmonary vasculature was found to be predicted by certain aortic and pulmonic
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valve relative intensities [24]. Although this work has not been applied to adult patients, it could theoretically help to
elicit information about the pressures at different points within the heart.
In several cases, radar has been utilized instead of direct, on-body measurement for detecting vital signs. Radar is
able to detect periodic changes caused by both breathing and the heart, allowing heart rate and respiratory rate to be
detected. Vinci et al. described a remote sensor that uses a six-point radar to monitor respiration and heartbeat [103]. It
uses a continuous 24 GHz wave and a radiated power of less than 3 microwatts. It captures these values noninvasively
in patients at rest. This is notable as it is a sensing modality that does not require attaching sensors to the human
body. This is particularly valuable in infants, in adults in severe conditions that cannot have additional attachments
placed on the body, and as a modality that improves patient quality of life by limiting on-body sensors. The sensor
designed in this paper does not have the limitations of other radar systems that require a wide frequency band to achieve
more accurate results. Because of the six-point receiver architecture, this sensor can accurately measure angle and
displacement by only measuring phase difference in backscatter patterns. Models regarding the permittivity of the skin
allow them to estimate that their signal has 1.52 mm penetration as well as estimates of blanket and clothing impact. As
a result, they can estimate where the edge of the torso is to aid in monitoring breathing. This provides an opportunity
to noninvasively measure respiration and heart rate. However, it requires known, fixed postures of the individuals.
Additionally, it will only work for one patient at a time. While this modality provides activity, displacement, and vitals
monitoring in controlled, clinical environments or within specific remote environments (such as in the bedroom while
asleep), it does not provide flexibility while moving. There are needs to extend such sensing systems to a variety of
environments.
Work by Li et al. explore the use of radar technology for vital sign monitoring [54]. Their system uses a hardware-
controlled clutter cancellation system. This allows their radar technology to identify the difference between the person
being monitored and background clutter that are likely present in rooms the person would be in. Authors propose taking
ka-band radar systems that are meant for motion sensing and modify them for vitals sensing. Authors discuss existing
work, design considerations for advancements, then opportunity to extend this to infant monitoring. The advancements
in radar usage have come through the detection of the right frequency band to use. Different frequencies were shown to
be able to go through different rubble with and without metal mesh. Authors then discuss the chip-level decisions that
need to be made to create CMOS Doppler-based motion detectors. This allows vital sign detection through obstacles
which can be important for noninvasive monitoring and for detection of vitals in emergency disaster scenarios. The
application, however, is not clear for advanced signal processing of multiple vitals.
3.1.2 Electrical Measurements. Remote ECG monitoring has been explored by a number of researchers, primarily to
solve the challenges that arise in noisy measurement. One issue that arises in continuous ECG monitoring, as with
wearable ECG implementations, is that signals are often hidden by the noise of activity. Li et al. presented an approach
for quantifying this noise [55]. While earlier approaches focused on labeling ECGs as either clean or noisy, the approach
presented by Li introduced five classifications, each with different amounts of information available to be extracted
from the ECG. They defined the noisiest strips as those where artifact obscures signals to the point that there can
be no confidence in any interpretation of the ECG. Strips with severe noise were those where some interpretation
could be made, but interpretations could be confused as to where the QRS complexes fell or to whether ventricular
flutter rhythms were present. In strips with moderate noise the QRS complex and presence or absence of ventricular
flutter rhythms could be assessed, but finer signals such as P or T waves could not be extracted. Minor noise was
the label given to strips with some amount of noise, but where P waves and T waves could be extracted. This level
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of noise allows for the analysis of atrial arrhythmias such as atrial flutter. Finally, clean ECGs were those where no
noise was present. The authors produced training data by adding three types of noise to the original clean dataset:
baseline wandering, electrode motion, and muscle artifact. They trained an SVM to classify strips based on the amount
of noise present and validated this classification scheme on real noisy data. This validation showed good agreement
between manually annotated labels and model output labels, with the greatest confusion present where samples had
been manually annotated as having minor noise, but the model labeled the samples as having moderate noise. The
authors note that a chief limitation of this work was that the model was not trained for or with an arrhythmia database,
which substantially lowers its effectiveness on samples with arrhythmias. Additionally, they note that methods based
on continuous features rather than discretely extracted features would be likely to show greater performance.
Once identified, several approaches have been implemented in order to account for and to correct motion artifacts.
Sriram et al. addressed this problem by utilizing a triaxial accelerometer [96]. ECG signals are usable as a means
of continuous biometric security. However, this continuous security is lost when the ECG signal is distorted with
motion artifact. This approach shows that supplementing the raw ECG signal with features extracted from acceleration
allows for accurate classification of ECG subject identity. They segmented signals to windows containing roughly four
heartbeats, averaged those four beats together, and then corrected for baseline abnormalities with linear interpolation
of q-minima and a high pass filter in association with the accelerometer features. These features then served to correctly
identify users using either a k-nearest neighbors or a Bayesian network classifier.
Another issue that arises with automatic ECG monitoring is that many abnormalities might be troubling in one
patient while normal in another. Chen et al. [19] described an approach to train ECG monitoring systems to discover
patient-specific abnormalities. This work utilized an accelerometer to reduce the number of false alarms in monitoring
systems. Over time, this system learns the normal for a given patient and uses a knowledge of this normal in order to
reduce false alarms.
3.1.3 Blood Flow. The American College of Cardiology and the American Heart Association (ACC/AHA) recently
released guidelines that suggest ambulatory blood pressure measurements, those taken at home in 15 minute intervals
including during sleep, should be captured to better understand a patient’s blood pressure and potential cardiovascular
risks [85]. The sphygmomanometric and oscillometric techniques are well-established as the predominant means by
which blood pressure is typically measured [73]. Both methods involve the inflation of a pressurized cuff, typically
around the patient’s upper arm and maintained at the level of the heart. The pressure in the cuff is increased to above
realistic values of the systolic blood pressure, and then slowly decreased. In the auditory sphygomomanometric method,
sounds called Korotkoff sounds can be heard just distal to the cuff as it deflates. The pressure at which these sounds are
first heard is the systolic pressure, and the pressure at which these sounds are no longer heard is the diastolic pressure.
In the oscillometric technique, minute variations in pressure as the heart beats against the pressurized cuff are measured
and the systolic and diastolic blood pressures are extracted from these variations [9]. Most at-home blood pressure
monitoring devices utilize the oscillometric technique, which is well-validated to have performance similar in quality to
the sphygmomanometric technique [38]. Recently, cuff-less blood pressure monitoring techniques have been explored
in order to record blood pressure.
The most common cuff-less approach thus far is to use photoplethysmography (PPG) and ECG to capture pulse
arrival time, pulse transit time (and pulse wave velocity), as surrogates for blood pressure, then use analytic techniques
to estimate the systolic and diastolic blood pressure values [59, 99]. If the posture of an individual is known, these
techniques are able to measure an estimate of the blood pressure, without disturbing the individual with frequent cuff
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inflations. However, the ECG and PPG combination can result in error in blood pressure estimation because it does
not appropriately account for artifacts that exist between the ECG measurement of a pulse and the PPG capture of
the pulse arrival time [14]. To account for this, researchers have turned towards dual PPG capture [21, 100] over a
small portion of the artery to account for pulse transit time, or bio-impedence measurements, which are better able to
locate the artery and avoid capturing blood profusion time into capillaries [40, 41]. Ballistocardiogram approaches look
to capture pulse arrival time through the small changes in pressure sensed by the waves in each pulse, providing a
method for capturing cuff-less blood pressure whenever participants are still [42, 45, 46]. These approaches all look to
address cuff-less blood pressure when the participant is in a fixed, known position, and provide the opportunity for
more frequent ambulatory blood pressure measurement.
3.1.4 Fluid Retention. While prior studies, such as Tele-HF and Beat-HF, attempted to use weight scales as a surrogate
for fluid retention in HF, the measurement of 3 pounds of weight change was not an alert that was able to reduce HF
readmissions [17, 48, 75]. A number of attempts to measure peripheral edema and fluid retention have focused on the
development of smart socks that look to measure fluid buildup in the ankles [26, 27]. A stretch sensor measures the
expanding duration of the patient’s ankle both as edema increases throughout the day and as edema increases over
time. The context-awareness allows the device to discard ankle measurements when motion, muscle contractions, or an
incorrect posture would interfere with the measurement. This sock was able to reliably determine the participant’s
posture, and measurements of fluid retention were well correlated, but additional study is needed to determine if this
measurement is accurate enough, and whether it can generate alerts early enough to intervene in HF patients. Yao et al.
came to similar conclusions of needing further study of their sensor to classify edema [109], as this remains an open
area of research.
3.1.5 Physical Activity and Posture. Activity, posture, and pain are important measurements in understanding symptom
and treatment effectiveness in patients diagnosed with cardiovascular disorders. Measurement of respiratory distress
in HF patients requires a measurement of posture, measurement of blood pressure through proxy measures such as
pulse transit time require a measurement of posture, as did the smart sock for fluid retention (Section 3.1.4). While each
sensor can capture posture, smartphones excel at this [112], often coupled with other applications tracking activities of
daily living [78, 81]. Recently, smartwatches have shown to accurately detect postures and exercises [69, 92], which is
important for patient monitoring, since smartphones are often in the proximity of the user, but often not physically on
the user, unlike smartwatches [101]. These can also provide important context to the measurements captured by the
other modalities discussed in this section [67].
3.2 Gaps
As richness of data increases across the variety of sensors, the potential for noise and missingness increases as well. It is
difficult to understand the context in which measurements are captured. Accuracy of posture detection and presence of
other noisy attributes impact the potential success of different sensing modalities. It is also unlikely a patient will wear
all sensors all the time, as this will provide excessive burden. While a measurement performed on occasion is likely
to be a high-quality measurement, continuous and automated measurements introduce a greater deal of variability
in the quality of measurements. For instance, a once-a-day measurement is likely to be a measurement where the
patient will intentionally position themselves appropriately and remain motionless during the measurement. A patient
monitoring their blood pressure will likely sit upright with their legs uncrossed, or a technician performing an ECG will
ensure that the printed ECG is taken at a point where the patient is motionless, and no artifacts are present. Conversely,
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more frequent or continuous monitoring must account for noise introduced by motion artifacts as well as from noise
introduced from other suboptimal measuring conditions. As such, a number of challenges remain in capturing the
necessary signals:
• Acoustic measurement: challenges in identifying the specific patient limit the potential for non-wearable sensors.
Wearable sensors must account for noise across a variety of motions, environments, and potential sensor
misplacement.
• Electrical Measurement: Continuous ECG requires multiple leads to be worn at the same time. Devices such as
the Apple watch provide potential for requesting ECG periodically when other sensing modalities dictate when
it is necessary [105], but the correlation between these modalities and necessary ECG readings has not been well
studied outside of AFib.
• Blood flow: Cuff-less blood pressure monitoring must extend to continuous, beat-to-beat measurements without
constantly restraining users to fixed, known postures.
• Fluid Retention/Weight Change: Edema measurements have not been clinically validated to show the degree of
fluid retention which must generate alerts that can clinically improve outcomes.
• Physical activity and pain: Remote measurement of acute and chronic pain remains an open challenge.
3.3 Opportunities
An additional source of noise can be introduced by the redundancy of signals that can exist. Different physical phenomena
can be measured by different modalities, many of which will produce slightly different readings. Heart rate can be
derived from multiple sources: auditorily by stethoscope, electrically by ECG, visually by PPG, and visually by radar. It
stands to reason that these redundant values could be exchanged for each other, but that exchange may not completely
be a one-to-one relationship. Transfer learning is an ongoing field of study that seeks to apply existing models to data
that was not used in training or was only used minimally in training [87, 88, 108]. Transfer learning could be applied to
this problem as a way to apply a single model to patients with disparate data collection modalities.
Missingness in data also increases as richness increases. While binary parameters used in many risk models (e.g.
history of HF, current diabetic status, etc.) are easy to collect and even possible to impute, continuous monitoring
opens the possibility of more complicated missingness. A battery may fail on a sensor leading to a variable period
of missingness. Wearable sensors may introduce missingness secondary to poor compliance or poor utilization. The
missingness introduced by gaps in continuous monitoring is more difficult to impute and presents a challenge in
building comprehensive models [57, 58]. A number of opportunities emerge for immediate and impactful research on
sensing signs and symptoms of cardiovascular disorders, illustrated in Figure 3, and listed below:
• Integration of multiple sensing modalities into a single platform, reducing the number sensors needed to be
worn. High impact areas appear to be the wrist (smartwatch) and chest (heart and lung sounds).
• Integration of machine learning techniques to help identify when longitudinal data capture is necessary, similarly
to ECG requests to verify periods of arrhythmias associated with AFib detection with the Apple Watch [105].
4 CONTINUOUS DATA COLLECTION AND ANALYTIC MODELS
Beyond the acute sensing and detection of symptoms related to HF, CAD, and stroke, analytic opportunities arise in the
processing of this data longitudinally and continuously. As discussed, the progression of CAD from stable and unstable
angina to NSTEMI and STEMI represent longitudinal changes that may have periods of rapid change interspersed.
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Fig. 3. Overview of basic sensor categories proceeding to physiologic value measured and to overarching disease state.
Similarly, untreated hypertension can lead to stroke if untreated. Changes in heart remolding in HF may be represented
by changes in heart sounds as captured by acoustic sensing. Patients living with HF may experience long term changes
in the amount of physical exertion required to perform activities of daily living. These changes may be gradual and
unnoticeable to the patient, but may represent worsening condition or recovery.
These cardiac conditions present a range of analytic techniques necessary to capture longitudinal changes in
continuously-sensed data:
• Continuous capture of acoustic sensing: Understanding how sounds change over time may allow for the identifi-
cation of new signals that represent earlier identifiers of worsening conditions or treatment effectiveness.
• Continuous capture of electrical signals: While the detection of arrhythmias may be present in surrogate measures
such as heart rate, detection of changes in ST segments of an ECG may allow for early alerts and acute care.
• Continuous capture of vitals signals: Understanding the changes in the variety of vitals signals captured and
how they may relate to each other can provide an understanding of improving or worsening risk factors relevant
to HF, CAD, and stroke.
• Continuous capture of physical activity: Physical activity and sleep are important functional measures of recovery,
and accurate, longitudinal understanding of functional change can be correlated with improved mortality and
prevention of adverse events.
4.1 Existing Technologies and Applications
4.1.1 Continuous Capture of Acoustic Sensing. Electronic auscultation is useful for deriving characteristics of other
parts of the cardiovascular system than sounds generated specifically by the heart valves. A carotid bruit is a sound
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created by turbulent blood in a carotid artery, often caused by narrowing that in turn is produced by atherosclerotic
plaques. Knapp et al. looked at the effectiveness of carotid bruit detection by electronic auscultation [47]. Out of 1,371
patients in this study, 84 were found to have carotid bruits by electronic auscultation. These patients were matched with
controls who did not have bruits, and both patients from each pair were assessed with duplex ultrasound to determine
extent of carotid stenosis. Bruit detection with electronic auscultation and manual annotation was found to have a
sensitivity of 88% for stenosis ≥ 50%, and a specificity of 58% with duplex ultrasound providing the ground truth.
Work by Palaniappan et al. surveyed machine learning techniques to further analyze lung sounds [79]. They evaluated
59 papers that used signal processing and machine learning techniques on a variety of lung sound problems including
normal breath sounds, abnormal breath sounds, and a series of sounds called adventitious lung sounds. This survey
highlights an important need by evaluating short term sounds, long term sounds, and identifying normal and abnormal
sounds across the different time periods. Most works in this survey focused on specific frequencies (between 150 and
2000 Hz, though they found that most work typically worked at 150 Hz), and evaluated machine learning techniques
such as k-nearest neighbor, ANNs, HMMs, GMMs, genetic algorithms, SVMs, and fuzzy logic to classifying a variety
of lung sounds. They found that by using piezoelectric microphones, contact microphones, and electric microphones,
and one commercially available lung sound instrument, they could design electronic stethoscopes that filtered out
heart sounds to capture necessary lung sounds. Similarly, one could use the same techniques to filter out the lung
sound to capture the heart sounds. Using standard time-domain and frequency-domain signal processing features,
algorithms were able to classify lung sounds with between 83-93% accuracy. Deep neural network techniques, such
as convolutional neural networks (CNN), recurrent neural networks (RNN), and long short-term memory networks
(LSTM) should be able to extract more time and frequency domain features rather than hand crafted features explored
by authors to achieve higher accuracy.
4.1.2 Continuous Capture of Electrical Signals. In clinical settings, most ECGs are performed as 12-lead ECGs. In these
ECGs, there are 10 electrodes attached to the patient and 12 different measurements taken from these electrodes. Each
provide a one-dimensional view of the magnitude of the vectors of all electrical impulses in the heart relative to a
given axis. Different axes allow for information to be obtained about the functionality about different parts of the heart.
Depending on the goals of remote monitoring, remote ECGs will typically only include a subset of these typical views.
As a result, methods that can accurately detect essential signals from minimal lead ECGs are necessary.
Work by Jambukia et al. surveyed machine learning techniques to analyze and classify ECG signals [43]. They
evaluated 31 papers that used signal processing and machine learning techniques in order to extract clinically significant
features from raw ECG signals. Most of the papers evaluated used the MIT-BIH arrhythmia dataset [64] for both training
and testing purposes. Two aspects of ECG classification considered were ECG beat classification for individual, isolated
beats, and ECG signal classification for interpretation of a longer signal. Some approaches evaluated involve signal
feature extraction followed by threshold-based algorithms such as the Pan-Tompkins algorithm. Other approaches
utilized various neural network architectures, with the authors finding that of the architectures studied, multilayer
perceptron neural networks provided the best performance. Recurrent neural networks, such as the long short-term
memory (LSTM) architecture, were not evaluated in this survey. Deep learning techniques have also been utilized for
ECG evaluation. Yildirim showed that a bidirectional LSTM architecture can reliably classify five different rhythms
from the MIT-BHI arrhythmia database [110]. This bidirectional LSTM model achieved accuracies greater than other
techniques. Additional deep learning techniques that combine CNN and LSTM have been used to detect AFib without
explicit feature extraction (such as R peak extraction) [4]. Further deep learning techniques have looked at a variety of
Manuscript submitted to ACM
A Survey of Challenges and Opportunities in Sensing and Analytics for Cardiovascular Disorders 17
processing individual beat anomalies and sequence anomalies [11], though time series presented to CNN models often
needs fixed windows of time to be pre-determined for evaluation. Additionally, some work uses a single lead [61] for
detecting arrhythmia, though it is likely at least two leads are currently necessary for other ECG feature extraction.
There is evidence to suggest that patients at risk of cardiac pathology benefit from more continuous remote ECG
monitoring. The mHealth Screening to Prevent Strokes (mSToPS) randomized clinical trial is an ongoing trial of 2659
patients investigating the benefit of continuous monitoring for AFib [97]. As reported by Steinhubl et al., the initial
phase of the trial discovered that for individuals at risk of AFib, home ECG monitoring was superior to routine care for
discovering new incidence of AFib. In the actively monitored group, there was a 3.9% diagnosis of new-onset AFib, vs
0.9% in the control. This resulted in earlier initiation of anticoagulative therapy (a preventative measure for stroke) in
these patients. However, this has also resulted in a higher healthcare utilization among these actively monitored patients.
This trial is still ongoing- the ultimate clinical impact is still unknown. Clinical outcomes are due to be published in a
3-year follow-up.
4.1.3 Continuous Capture of Vitals Sensing. Ultasonography is a technique that uses ultrasonic sound waves to
produce images of tissues beneath the skin. Ultrasonography is valuable for visualizing structures that are unreachable
noninvasively. In hospital settings, point-of-care ultrasound has increasingly grown in utilization as mobile ultrasound
systems become cheaper and comparable in quality to larger ultrasound systems [65]. Point-of-care ultrasonography is
useful as a tool that physicians can bring to the bedside for aid in diagnosis, much like a stethoscope, but deep learning
techniques are necessary to evaluate the ultrasound images and classify changes in conditions.
Ultrasonography can also be used to evaluate the fluid status of the lungs. As described in Assaad et al., lung
ultrasound is a valuable tool for quickly assessing the health of a patient’s lungs [7]. Certain visual findings, such
as “B-lines” are highly associated with edema and various pulmonary pathologies. These visual findings also change
very rapidly, reflecting the present disease state more accurately in some cases than measures such as blood oxygen
saturation. Lung ultrasonography is also useful in differentiating between cardiogenic and noncardiogenic pulmonary
edema; cardiogenic pulmonary edema typically shows more uniform findings and plural effusion (fluid buildup in the
tissue surrounding the lungs). Lung ultrasonography is an underutilized technique in medicine and lacks standardization
in training and implementation.
Work by Bhuyan et al. explores an exciting possibility of wearable ultrasound for the monitoring of internal function
noninvasively [15]. In order to create a small form factor that could be used to measure organ function with wearable,
remote ultrasound, they created a small, flexible probe through a flexible PCB integrated circuit. They also used a system
that has only one transmit and one receive channel to avoid excess signal degredation. This system has a bandwidth of
10 MHz, power consumption of 6.72 mW per channel, and uses 16 such channels to measure a 5.6 mm x 1.6 mm area.
They used classical image processing with ultrasound for their validation. Their system, however, used an attached
cable to measure. There is an opportunity to create a remote, continuous version of such a system if a flexible PCB-based
wearable ultrasound with necessary battery and wireless transmission capabilities were added, but, computer vision
techniques are needed to enhance the analytic component of the wearable ultrasound.
Echocardiography is the practice of using ultrasound in order to visualize the structures of the heart. Echocardiography
can take place either as an invasive transesophageal echocardiography (TEE) or as the noninvasive transthoracic
echocardiography (TTE). Many different aspects of the heart can be described and quantified via echocardiography
[50], including size, function, and mass of various structures of the heart. Measurement of these parameters aids in the
diagnosis of HF. For instance, left ventricular mass or poor emptying are markers of HF. Valvular disfunction, such as
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stenoses or regurgitations can be directly observed. These measurements also aid in assessing cardiac function in CAD,
particularly following MI; injured portions of the cardiac wall will often move less than they normally would.
Various groups have found preliminary success in applying deep learning computer vision techniques to the analysis
of ultrasonographic images. The first step in automatic analysis of ultrasonographic images is to recognize the view in
question. Østvik et al. describe the use of a convolutional neural network (CNN) to classify TTE images according to the
view being presented [77]. This method showed classification high accuracy in distinguishing among seven different
TTE views. Additionally, the authors described a technique for extracting 2D slices from 3D images and achieved a
mean error of 4°.
Techniques for measuring edema include cuffs that track ankle circumference and measurement of electrical
impedance. Weight monitoring is sometimes used as a proxy for tracking edema, as edema co-presents with fluid
retention. There has been success in implantable impedance monitors to measure pulmonary edema. Yu et al. found that
intrathoracic impedance serves as a predictor for imminent hospitalization due to fluid overload [111]. In a population
of 33 patients with HF, a device consisting of a pacemaker and defibrillator was implanted. The device measured the
impedance between those two leads. This study found that there was a significant decrease in impedance prior to
hospitalization with fluid overload. This decrease began on average two weeks prior to hospitalization and continued
through the date of hospitalization.
Impedance monitoring has also been implemented in noninvasive and ambulatory monitoring systems. Weyer et al.
describe a system that incorporates both ECG and noninvasive impedance cardiography [106]. This device includes
Bluetooth connectivity and a battery that lasts for up to 21 hours. This system could be implemented for long-term
monitoring in patients with HF to monitor pulmonary congestion and to potentially allow remote interventions before
hospitalization is necessary.
The internal and external jugular veins provide drainage from the head into the heart. The right jugular veins are
positioned almost directly above the right atrium, and therefore the pressure within them is very closely tied to the
pressure of the right atrium. The external jugular vein’s filling level indicates the pressure within the right atrium and
will be distended in cases of right heart failure. Pulsations can be observed with great difficulty in the internal jugular
vein. These pulsations provide evidence as to the relative timing and forces involved in right atrial contraction, atrial
relaxation, right ventricular contraction, venous filling after the closing of the tricuspid valve, and emptying of the
atrium after opening of the tricuspid valve.
As venous pressures are so much lower than arterial pressures, measurement of the jugular venous pulse is much
more difficult than the measurement of arterial pulses. However, Amelard et al. were recently able to utilize a technique
called PPG Imaging (PPGI) as a viable technique to correctly measure the jugular venous pressure [3]. This technique
uses a system located approximately 1.5 meters away from a supine patient. A light shines on the patient and the
reflected light is analyzed to identify pulsations. The arterial pulsation from the carotid artery is easier to detect, and
the jugular pulsation can be identified as a corresponding inverted pulsation at a location near but lateral to the arterial
pulsation. In this study, the ground truth arterial waveform was verified with a PPG measuring device. Pertinent
clinical features were consistently able to be extracted from the venous waveform, including the c, v, x, and y waves
(corresponding to the contraction of the right ventricle, systolic filling of the right atrium, relaxation of the right atrium,
and beginning of the filling of the right ventricle). In about half of subjects, the a wave was also observed (corresponding
to the contraction of the right atrium). The ability to regularly monitor and quantify these waveforms could allow for
new techniques in monitoring right heart function. Ballistocardigrams may be another way to measure this venous
pressure.
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Signals that capture continuous blood pressure, described in Section 3, may also be extended to capture a variety of
heart rate, heart rate variability, blood pressure, respiratory rate, and changes in these values. Obstructive sleep apnea,
a condition in which airwaves are restricted causing the body to wake up from sleep to begin breathing again, increases
heart rate, respiratory rate, and blood pressure, keeping patients from falling asleep. This has a direct relationship
with blood pressure and nocturnal nondipping hypertension, and treatments for apnea have shown to be correlated
to improvements in blood pressure [91]. This means approaches for measuring cuff-less blood pressure cannot be
restricted to periodic, ambulatory measurements, but must transition to continuous beat-to-beat measurement and
interpretation.
Finally, telemonitoring trials for HF readmission have tracked longitudinal measurements of symptoms, vitals, and
patient qualitative reports [17, 48, 75]. In the Tele-HF study, a number of vitals signals and patient reported outcomes
generated alerts for interventions if the values were below a specified threshold, or represented a significance drop from
the prior day’s values. However, the study was unable to find a statistically significant reduction in readmissions in the
intervention arm. Ong et al. in the Beat-HF study tried to use some machine learning techniques to further identify
risks of adverse events, and while the study was unable to reduce readmissions, the techniques did show some promise
in stratifying patients [84], as did further statistical techniques applied to the Tele-HF data [48, 68]. With the addition of
more signals captured, and techniques that can better account for varied time-domain aspects of analytics, it is possible
that better just-in-time alerts can be generated for preventing future recurrent HF events.
4.1.4 Continuous Capture of Physical Activity. For cardiovascular disorders, the detection of activities and postures
is important in understanding the other biomarkers captured, providing context for their readings. For example, at
nighttime, knowing the posture of the user provides context for dyspnea measurements and heart sound recordings for
HF patients. In addition to providing context for the other vitals measurements related to cardiovascular disorders, the
change in physical activity performance can show increasing effects of HF symptoms, pain as a result of CAD, and acts
as a surrogate for the general well-being of these patients.
Many research-oriented activity recognition platforms focus on the detection of activities of daily living [13, 66, 67, 71]
and understanding daily exercise intensities. These sensors are capable of tracking sports movements in the healthy
and measure sedentary time in the elderly, and come in many forms of smartwatches, smartphones, smartwatch-sized
sensors [66, 69], embedded within shoes, and most recently within eTextiles [1, 113].
HF participants have had improved outcomes in mortality and readmission when involved in cardiac rehabilitation
programs that encourage continuous physical exercise [35]. This physical exercise routine has shown that measurements
in improved peak exercise capacity correlate with improved cardiovascular outcomes. Home-based cardiac rehabilitation
systems centered on physical activity detection in order to quantify a home-based exercise routine [60]. However,
such systems do not yet quantify improvement directly from physical activity measurements. This is necessary since
adherence in cardiac rehabilitation programs is often quite low [44].
4.2 Gaps
Deep learning techniques have made the exploration of time series data more fruitful with the development of automatic
features that represent longitudinal risk or outcomes. Techniques such as attention-based LSTMs have shown promise
in exploring continuous time-series data to predict clinical mortality, decompensation, and length of stay, which
outperform hand-crafted feature extraction, and other deep-learning techniques that do not find focus on specific
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periods of time, in intensive care unit data [95]. However, these techniques have not been applied to this remote data
yet because the integration of these sensing techniques have not yet occurred.
A number of the analytic techniques tied to the use of these new sensing paradigms have focused on the diagnosis of
specific anomalies or classification of specific types of sounds or signals captured. What is still needed is the following:
• Integrated sensors that can capture signals frequently, or continuously, over entire study periods.
• Machine learning techniques that can explore multiple windows of time over multiple combinations of available
signals in order to quantify trajectories in signals, identifying longitudinal patterns and changes in signal that
may be indicative or worsening conditions or treatment effectiveness and recovery, extending beyond anomaly
detection and signal classification.
4.3 Opportunities
One way in which advanced work in analytics could be incorporated is in better personalized monitoring for risk of CAD.
As previously discussed, CAD is a condition often characterized by gradual worsening of chest pain that culminates in
a heart attack. Ideally, monitoring systems would be able to follow gradual changes prior to the rupture of a plaque that
causes a heart attack. In the early stages of CAD, activity monitoring could be used to assess wellness. By tracking a
certain threshold of activity that the patient does not (or cannot) exceed, a monitoring system can estimate the severity
of angina. As that threshold begins to decrease, the patient’s angina is likely increasing and greater intervention may
be warranted. The monitoring system for a patient at risk of CAD should also include an ECG system to watch for
changes associated with a heart attack. If any electrical changes concerning for a heart attack begin to appear in the
patient’s ECG, then emergency services would be required. Earlier interventions are associated with better outcomes,
and a monitoring system like this coupled with improved analytics could potentially allow for earlier treatment, leading
to less overall damage and better patient outcomes.
Improved analytics could also be implemented to better treat valvular diseases. Unlike the other pathologies discussed
here, there are few risk models for predicting future valvular heart disease. However, advanced analytics could be
implemented to allow for earlier detection of valvular disease. As discussed above, these abnormalities change the
way in which blood flows through the chambers of the heart, producing turbulence that can be detected as sound. The
most straightforward evaluation for valvular disease in remote wearable settings would involve electronic stethoscopes
continuously monitoring the patient’s heart sounds. By learning the normal sound profile of a patient, new changes
and murmurs could be quickly identified. After identifying a particular valvular disease and its associated murmur,
long-term monitoring with electronic stethoscopes could be used to characterize the severity of the valvular insult;
most murmurs initially increase in intensity, but in later disease stages decrease in intensity. Rather than risking false
negative screening in physical examinations, a longitudinal monitoring system could detect the changes along this
trajectory to allow for more informed decision making. As a more advanced option in monitoring valvular disease,
miniaturized ultrasound probes could be incorporated into a wearable system. These could be used for imaging and
analyzing the valvular parameters such as cross section and flow. Additional work into computer vision interpretation
of ultrasound images would be necessary in order to automatically process these signals. Vital monitoring can also
directly feed into an understanding of valvular disease. In particular, blood pressure can reflect aortic valve lesions.
Finally, systems to monitor valvular disease could monitor symptomatic disease progression. As many types of valvular
disease may ultimately lead to HF, the opportunities presented above for HF apply here as well. Foremost among them
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would be activity recognition, where late stage valvular disease can manifest with a loss of stamina in day-to-day
activities.
Opportunities:
• Improved Machine Learning Processing of Existing Sensor Modalities: Development of machine learning tech-
niques that can extract meaningful data from non numerical sources, expanding on the computer vision work
done in automatically processing and interpreting ultrasound images.
• Time-SeriesMachine LearningModels: Development ofmachine learning techniques that can process longitudinal
data and account for multiple channels of data, sampled at different frequencies, and with different segment
lengths of importance, are required to develop new risk prediction techniques and alerts based upon continuously
captured data.
5 CLINICAL INTERPRETABILITY, ANALYTIC MODELS, AND TREATMENT PARADIGMS
Clinical risk prediction models and those that predict adverse events have helped guide medical treatments and improve
patient care. These techniques, with machine learning modeling, have the potential to improve clinical care in both the
acute care settings [90] and remote care settings. This includes understanding the diagnosis and progression of diseases
and the personalized patterns and signals that can be captured by advances made in categories listed in Sections 3
and 4. Some preliminary work has been conducted in clinical trials on HF patients, understanding distinct patient
phenotypes within the disease. In one such HF trial, clinically-distinct clusters of patients were found to have different
time-to-event predictions and outcome rates [2]. Another relevant clinical trial in HF patients is the Treatment of
Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial [22, 83]. The purpose of
this trial was to determine if a treatment designed specifically for HF patients with preserved ejection fraction could
improve outcomes, a patient population where such treatments have not been found to universally treat these patients.
This trial was also unsuccessful in showing that HF patients treated with Spironolactone had better outcomes [83].
However, due to some issues with data gathered in certain regions, investigators began taking a closer look at subsets
of patients, to determine if specific patients were actually helped by the treatment. The investigators found regional
variations lead to different treatment effectiveness in cohorts of participants [22, 80]. This indicates that HF patients
diagnosed with preserved ejection fraction may benefit from cluster analysis, looking at personalized differences in
outcome rates where different treatments may be helpful for different subsets of patients. These provide for the basis of
the following needs in HF, CAD, and stroke:
• Personalized models: as illustrated by the TOPCAT findings, these diseases are quite complex and understanding
the person-to-person variation allows for specific risk prediction based upon data collected, along with matching
techniques that allow for comparison to patients most similar to the individual modeled.
• Dynamic adaptation: models must account for the varied data types potentially collected, the varied rate at
which they are collected, how well to link them to data gathered in acute care settings, and be able to update as a
disease progression worsens or treatment regimen proves effective, including providing confidence metrics that
suggest the collection of additional data, if necessary.
• Interpretable machine learning: as the data size progresses, medical models must be able to explain the driving
risk factors in a manner interpretable to clinicians in order to guide treatment decision making.
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5.1 Existing Technologies and Applications
5.1.1 Risk Prediction Models. Much of stroke risk prediction is tied to the risk associated with AFib. In particular, it
may be appropriate for patients with AFib to undergo anticoagulation therapy in order to reduce their risk of stroke.
Anticoagulation therapy is any therapy that works to reduce the rate at which blood clots form. This type of therapy can
be beneficial by preventing thromboembolic stroke. Conversely, this type of therapy can be detrimental by promoting
life-threatening bleeds, such as in hemorrhagic stroke. Therefore, implementation of any anticoagulation therapy must
be implemented with great care. In addition to models that predict only stroke risk, the ACC/AHA Pooled Cohort
Equations treat stroke and CAD together.
CHA2DS2-VASc is a model that predicts 12-month thromboembolic event rate (including stroke, pulmonary embolism,
and peripheral thromboembolism) in patients with AFib who are not undergoing anticoagulation therapy [56]. Creation
of this model drew upon the efforts of and improved upon multiple older models in order to apply more broadly and
accurately to diverse patient populations. One chief exclusion in this model is that only patients with non-valvular AFib
are considered. The parameters considered in this model are presence of HF, hypertension, age, diabetic status, history
of stroke or other thromboembolic event, history of any vascular disease, and gender. This model aids clinicians in
prescribing anticoagulants, which increase the risk of bleeds but decrease the risk of thromboembolic events (including
stroke).
The HAS-BLED model was created to predict the risk of bleeding in anticoagulated patients with AFib [82]. The
parameters included in this model are hypertension, history of liver or kidney dysfunction, history of stroke, history of
bleeding, difficulty calibrating oral anticoagulation therapy, use of alcohol, and use of certain drugs that may increase
bleeding risk. Recommendations by groups such as the European Society of Cardiology [63] are that CHA2DS2-VASc
and HAS-BLED be used in conjunction for informed decision making, and that HAS-BLED alone should not be a reason
to withhold anticoagulant therapy.
Other models have been produced to predict general risk of stroke. The MyRisk_Stroke Calculator is a model to
predict 10-year risk of stroke [72]. This estimator was built on a prospective dataset where collection began in 1992
and validated with a second dataset with collection beginning in 1998. Follow-up was through the year 2007. In this
cohort, the parameters found with an association to stroke risk were age, gender, education status, high blood pressure,
smoking status, alcohol consumption, activity levels, anger, depression, and anxiety. Additionally, comorbidities such as
renal disease, diabetic status, HF status, CAD, peripheral arterial disease were included as features in this model. The
model was created as a Cox proportional-hazards model and predicts 10-year risk of any type of stroke.
Another stroke risk model is the QStroke score [37]. QStroke was developed to be used for all patients without
history of stroke but intended specifically to be used as a supplement or replacement for CHA2D2-VASc in predicting
risk associated with AFib. The QStroke model features the following as parameters: age, gender, ethnicity, Townsend
deprivation index (an index related to socioeconomic status), smoking status, body mass index, systolic blood pressure,
blood lipid levels, and family history of CAD. Hypertension, diabetic status, AFib status, HF status, CAD, presence of
rheumatoid arthritis, renal disease, and valvular disease were also included as pertinent comorbidities. The QStroke
model was created as a Cox proportional-hazards model and predicts 10-year risk of any type of stroke.
Many attempts have been made to assess the risks of developing CAD. Among the most current of these are from
the ACC/AHA Task Force on Practice Guideline [31]. That work introduced a set of models termed the Pooled Cohort
Equation to predict a primary CAD event within 10 years. The predicted risk in this model is based on age, gender, race,
blood pressure (systolic and diastolic), diabetic status, smoking status, various cholesterol lab values, and on certain
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current medications (hypertension control, statins, or aspirin). This risk prediction tool was built to predict any type of
“hard” atherosclerotic-based disease, and therefore in addition to predicting future CAD is also predicts future stroke.
However, it does not distinguish between risks for these two different outcomes and treats them both as a positive
outcome.
5.1.2 Remote and Dynamic Models. Remote and telemonitoring studies that use telephones and call-centers as the
primary source of data have been used to track HF patients, in the hope of reducing heart failure admissions. These
systems are intended to track patient symptoms, including impact of medication, weight gain (as a surrogate for edema),
and depression, to identify early signs of decompensation aimed at providing interventions that prevent hospital
readmissions in HF patients. In Tele-HF, Krumholz et al. found that a self-report telemonitoring system was not able to
reduce readmissions in heart failure patients based upon daily reports of symptoms, medication usage, weight, and
depression [48]. Ong et al., in the Beat-HF trial, looked to automate some of the data collection surrounding blood
pressure and weight, with machine learning risk models to drive interventions, but found similarly that HF readmissions
were not reduced [75]. Anker et al. surveyed meta-analyses and prospective clinical trials that evaluated the efficacy
of telemonitoring in patients with HF [5]. They found disagreement between the efficacy of telemonitoring for HF in
different types of trials, but stress that the outcomes of telemedicine depend on personalization to the particular patient.
Models that predict risks within varied windows of time have, thus far, been restricted to medical settings. Henry et
al. used a rolling model to predict the risk of sepsis in a hospital setting, selecting important features and identifying
dynamic risks of sepsis within a single hospital admission [34]. Such dynamic models could be adapted to remote and
longitudinal settings, but have not done so yet.
5.1.3 Interpretable Machine Learning. A recent push in the machine learning field has been to explain predictions
provided by deep learning methods that are generally considered black box techniques. Ribiero et al. developed a
technique by which local logistic regression models are able to identify the reasons a particular prediction is made
based upon the variables that generated the prediction of that element and similar model elements [86]. This work
demonstrates model interpretability, which comes naturally in CNN deep learning models that can visualize data in
intermediate models but becomes much more complicated in time-series based models such as LSTMs. Additional
machine learning techniques look to automatically cluster patients and explain the phenotype discovery [33], while
also learning to predict multiple outcomes at the same time across different patient types [98], but work on explaining
the findings remains in preliminary stages [30].
Interpretability also indicates the confidence in estimations, and understanding what data helps and hurts the
predictive accuracy of techniques. In work aimed at improving real-time context and activity detection, Ardywibowo et
al. evaluated selected sensors to improve HAR with constraints on the types of sensors and the power those sensors
consume [6]. Work by Solis et al. use the idea of uncertainty quantification in order to direct users to gather more data
in real-time, diet logging settings [94]. Uncertainty quantification is an emerging field of interpretable machine learning
that has the ability to guide confidence in predictions collected as well as suggest additional data that patients and
clinicians should consider collecting.
5.2 Gaps
Existing models for predicting risk in cardiovascular conditions rely on sparse data that are measured on rare occasions.
Many parameters are trivial to measure (age, gender), and many parameters are Boolean values relating to history. In
comparison to the data produced continuous monitoring systems, these data are sparse and likely overly-simplistic.
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There are two chief ways in which the limitations posed by this sparsity of data can be overcome with richer data:
existing models can be updated to include richer data sources, and richer data sources can be analyzed for anomaly
detection and rare event detection.
The following gaps remain in developing personalized analytic models based upon the remote sensing data gathered:
• Integration of sensing data with acute care data and outcomes for robust risk prediction models.
• Development of dynamic models that are flexible to the types of data collected, the windows of data collected,
and the changing in patient condition throughout observation.
• Interpretable machine learning to explain the predictions of these complex models, and help guide clinical
decision making, including identifying similar patients and explaining potentially new phenotypes that might be
discovered.
5.3 Opportunities
Existing models to quantify disease state and future disease risk could be improved through the implementation of
richer data sources into the mode. The NYHA Functional Classification of HF relies in part on physical activity levels.
The levels are subjective, with definitions in part of “no limitation of physical activity” (class I), “slight limitation of
physical activity” (class II), “marked limitation of physical activity” (class III), and “unable to carry on any physical
activity” (class IV). These classes are inherently subjective, and therefore susceptible to variability between patients
with the same underlying disease state. Augmenting this classification with patterns detected from signals such as
HAR and effort involved in activity (such as via heartrate monitoring) would allow for objective measurements from
beyond the limited scope of direct patient-physician contact. The increase of objective measurements would likely lead
to updates to existing models and better information to aid in making clinical decisions.
Existing models could also be improved by the detection of rare or uncommon events. For instance, when a patient
presents with AFib, the duration of the AFib is typically unknown. As discussed above, the CHA2DS2-VASc score can
aid physicians in predicting stroke and the appropriateness of implementing oral anticoagulation therapy. However, the
parameters which contribute to the CHA2DS2-VASc score are simplistically sparse. Age and gender are (for cardiac
risk purposes) nonmodifiable risk factors. Each of the other parameters are positive if the patient has ever had the
given event once in their life: HF, hypertension, stroke/TIA/thromboembolism, vascular disease, or diabetes. It stands
to reason that this model may be improved from richer data, such as the pattern or frequency with which the patient
experiences episodes of AFib. Addition of this richer data to the model could potentially result in a model which is better
able to discriminate between those at risk of stroke and those at lower risk of stroke, allowing for more appropriate and
judicious use of oral anticoagulants.
The emergence of new sensing and internet of things (IoT) technologies creates a need for new models to incor-
porate new data for better prediction and understanding of disease states. The drastic increase in technology such as
smartphones and smartwatches allows for new rich data sources, and also creates a need for the utilization of these data
sources. Recently, smartwatches have been adapted to detect conditions such as AFib [16]. Further work should look at
implementing these new modalities into longitudinal risk models. For instance, HAR recognition could be implemented
as a parameter in monitoring activity tolerance in patients with HF. This could supplement the existing subjective
measures of heart failure with newer objective measures.
Ultimately, data from new rich data sources is only valuable so far as it contributes to improving the quality of
patient healthcare. In order for this contribution to take place, models must generate actionable feedback that can be
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used for informed clinical decision making. Rather than presenting modeling through a black box approach where
data is supplied to the model and an answer is returned, it is desirable that the reasoning behind the risk score is
understandable. If a model is interpretable, then the factors leading to a given score can be understood and interventions
made to address the risk and to improve patient outcomes. Additionally, the greater the interpretability of a model, the
more information that the physician and patient are able to have about the overall disease state. As this information is
understood by the physician and the patient, it can be used to better inform and guide care. As a result, the following
opportunities exist for immediate and impactful machine learning research:
• Machine Learning models with cross-sectional and time-series data: Integration of sensing data with acute care
data and outcomes for robust risk prediction models.
• Development of dynamic models that are flexible to the types of data collected, the windows of data collected,
and the changing in patient condition throughout observation.
• Interpretable machine learning to explain the predictions of these complex models, and help guide clinical
decision making, including identifying similar patients and explaining potentially new phenotypes that might be
discovered.
• Transfer Learning: transfer learning techniques will be able to take developed models and adapt to a variety
of signals captured, a variety of patients modeled, or a combination therein, improving the flexibility of any
analytic techniques developed to advance the prior three opportunities.
6 DISCUSSION AND CONCLUSION
We surveyed the field of sensing technologies and machine learning analytics that exist in the field of remote monitoring
for cardiovascular disorders. Through the evaluation of these sensing modalities and machine learning techniques, we
highlighted the potential for addressing three critical areas of need for care in patients diagnosed with heart failure,
coronary artery disease, and stroke: 1) the need for sensing technology that can track longitudinal trends in signs and
symptoms of the cardiovascular disorder despite potentially infrequent, noisy, or missing data measurements; 2) the
need for new analytic techniques that model data captured in a longitudinal, continual fashion to aid in the development
of new risk prediction techniques and in tracking disease progression; and 3) the need for machine learning techniques
that are personalized and interpretable, allowing for advancements in shared clinical decision making. We highlight
these needs based upon the current state-of-the-art in smart health technologies and analytics and discuss the ample
opportunities that exist in addressing all three needs in the development of smart health technologies and analytics
applied to the field of cardiovascular disorders and care. Whereas the progression of smart health technologies in
these needs has demonstrated success in fields such as HAR and physical disorder monitoring, the opportunities for
addressing cardiovascular care are many.
These cardiovascular disorders are often very complex conditions characterized by multiple changes in a patient,
many of which are slow and difficult to notice. However, systems could be built to take into account and monitor
many different changes in order to track disease progression and to allow clinical decisions to be made before rapid
decompensations. As disease progresses, regular monitoring of heart sounds could be used in order to track heart
remodeling. Instead of noticing these sounds in an acute care visit, computer-aided auscultation though wearable
electronic stethoscopes could allow for earlier detection. Quantitative edema tracking would allow for monitoring
functional changes within the heart. As pulmonary edema increases, clinicians are able to tell that left heart function is
decreasing. Changes in ECG signals may indicate progression of CAD disorders, that may result in additional patient
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pain, prior to leading to heart attack. As a patient’s condition worsens, they may gradually lose the stamina to walk
certain distances or to perform a certain amount of activity, demonstrating changes in physical activity capacity,
respiratory rate, or sleep quality. These changes may be so gradual that patients may not notice them. Instead, new
analytics for progression could instead build activity recognition into the modeling to understand slow changes in
baseline function. In this, departures from a patient’s baseline level of activity would be significant and could be useful
information for guiding clinical care. Similarly, alterations in blood flow may lead to changes in urination habits. As
blood flow to the kidneys might be restricted during the day and increased at night due to postural changes, the kidneys
will produce more urine at night. Tracking frequency of nocturnal urination could provide more clues as to overall
health. Note that this will be sensitive, but not specific for heart failure. Additional measurement of hemodynamic
characteristics, such as hypertension, may show treatment effectiveness and better guide the improvement of factors
that would lead to conditions such as stroke. In total, a comprehensive system to track the progression of cardiovascular
disorders should incorporate a body of integrated sensors, capture this data over longitudinal periods of time, and as
a result, enable new advancements in machine learning techniques that can make best use of this data to help guide
patient and clinician alike in improving patient care.
This survey highlighted the needs in developing smart health applications to treat HF, CAD, and stroke, and the risk
factors associated with them. It reviewed the existing technologies, highlighting the current gaps in solutions presented
for those needs. Finally, it presented a series of opportunities, including advanced analytic techniques to be developed
once new sensing solutions are available that can guide impactful changes in the way patients with cardiovascular
disorders are cared for.
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A NORMAL CARDIAC PHYSIOLOGY
In order to better understand the opportunities discussed in this work, we provide a brief medical review of normal
function of the heart.
The heart consists of four chambers- two atria and two ventricles, one of each composing the right heart and one of
each composing the left heart. The two atria (singular atrium) drive blood into the two ventricles, and the ventricles
drive blood forward. The right heart takes deoxygenated blood from the body and pumps it through the lungs. The left
heart takes blood from the lungs and pumps it through the body. The left heart does more work than the right heart,
and the pressures that it produces are higher than the pressures produced by the right heart. There are four valves in
the heart. The right heart valves are the tricuspid and the pulmonic. The tricuspid valve is between the right atrium and
ventricle, the pulmonic valve is between the right ventricle and the lungs. The valves of the left heart are the mitral and
the aortic. The mitral valve is between the left atrium and ventricle, while the aortic valve is between the left ventricle
and the rest of the body.
Manuscript submitted to ACM
32 Hurley et al.
The heart cycles through two phases as it beats- systole and diastole. In systole, the heart contracts and drives blood
forward. In diastole, the heart relaxes and refills with blood. One common metric of cardiac function is blood pressure,
represented by two numbers- a systolic and a diastolic pressure. The systolic pressure is the pressure in the arteries as
blood is actively pumped out of the heart. The diastolic pressure is the pressure in the arteries as the heart relaxes. The
heart typically spends about one third of the time in systole, and two thirds of the time in diastole. The normal heart
produces two sounds, called S1 and S2. S1 is caused by the closing of the mitral and tricuspid valves at the beginning
of systole. Their closure prevents the backwards flow of blood from the ventricles into the atria. S2 is caused by the
closing of the aortic and pulmonic valves. Their closure prevents the backwards flow of blood from the body or lungs
backwards into the heart.
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